TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
SPS Pharma Solutions AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
734,447
|
642,050
|
576,917 |
| Financial expenses |
3,362
|
5,584
|
5,452 |
| Earnings before taxes |
73,001
|
-23,859
|
15,971 |
| EBITDA |
98,130
|
8,266
|
42,243 |
| Total assets |
723,799
|
645,328
|
517,388 |
| Current assets |
419,589
|
350,105
|
264,115 |
| Current liabilities |
191,238
|
220,145
|
183,255 |
| Equity capital |
471,626
|
407,401
|
312,768 |
| - share capital |
10,313
|
10,130
|
9,459 |
| Employees (average) |
306
|
322
|
312 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
65.2%
|
63.1%
|
60.5% |
| Turnover per employee |
2,400
|
1,994
|
1,849 |
| Profit as a percentage of turnover |
9.9%
|
-3.7%
|
2.8% |
| Return on assets (ROA) |
10.6%
|
-2.8%
|
4.1% |
| Current ratio |
219.4%
|
159.0%
|
144.1% |
| Return on equity (ROE) |
15.5%
|
-5.9%
|
5.1% |
| Change turnover |
80,820
|
24,197
|
124,902 |
| Change turnover % |
12%
|
4%
|
28% |
| Chg. No. of employees |
-16
|
10
|
34 |
| Chg. No. of employees % |
-5%
|
3%
|
12% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.